Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.
Start price
03.03.26
/
50%
€20.55
Target price
03.03.27
€29.92
Performance (%)
34.31%
Price
14.07.26
€27.60
Summary
This prediction is currently active. With a performance of 34.31% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 03.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (CPRX) had its price target raised by Citigroup Inc. from $33.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€18.50
07.11.25
07.11.25
€28.60
07.11.26
07.11.26
49.23%
14.07.26
14.07.26
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€15.01
14.03.24
14.03.24
€24.74
14.03.25
14.03.25
26.78%
15.03.25
15.03.25